Dr. Charles Allen Taylor Ii, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4899 Cliffside St, Catawba, NC 28609 Phone: 828-241-1179 |
News Archive
Researchers have developed and validated a new tool to help identify unstable or high risk atherosclerotic plaques-inflamed fatty deposits in the artery wall and a main contributor to cardiovascular disease (CVD). This breakthrough may lead to better identifying which plaques are considered at the highest risk for rupturing and causing a heart attack or stroke.
Targeted alpha therapy has the potential to selectively eliminate HIV infected cells from the central nervous system, according to a recent study co-authored by the JRC. The study shows that a specific human antibody labelled with the alpha emitter bismuth-213 can penetrate the blood brain barrier and selectively target and destroy HIV-infected cells while sparing non-infected healthy cells.
The global leader in medical technology for endovascular aortic repair (EVAR), Medtronic plc today announced that it plans to develop a stent graft system for less invasive treatment of thoracoabdominal aortic aneurysms under an exclusive patent license agreement with South Dakota-based Sanford Health.
A psychiatrist at Washington University School of Medicine in St. Louis writes in the Journal of the American Medical Association (JAMA) that although mortality from cardiovascular disease has declined in the United States over the past several decades, patients with severe psychiatric illness are not enjoying the benefits of that progress.
› Verified 2 days ago